Log In
BCIQ
Print this Print this
 

UGP302

  Manage Alerts
Collapse Summary General Information
Company UGP-Therapeutics Inc.
DescriptionUndisclosed peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerNordic Bioscience A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today